Edward Roddy e.roddy@keele.ac.uk
Improving outcomes for patients hospitalised with gout: a systematic review.
Roddy
Authors
Abstract
OBJECTIVES: Hospital admissions for gout flares have increased dramatically in recent years, despite widely available, effective medications for the treatment and prevention of flares. We conducted a systematic review to evaluate the effectiveness and implementation of interventions in patients hospitalised for gout flares.
METHODS: A search was conducted in MEDLINE, Embase and the Cochrane library, from database inception to 8 April 2021, using the terms gout and hospital and their synonyms. Studies were included if they evaluated the effectiveness and/or implementation of interventions during hospital admissions or emergency department attendances for gout flares. Risk of bias assessments were performed for included studies.
RESULTS: Nineteen articles were included. Most studies were small, retrospective analyses performed in single centres, with concerns for bias. Eleven studies (including five randomised control trials) reported improved patient outcomes following pharmacological interventions with known efficacy in gout, including allopurinol, prednisolone, non-steroidal anti-inflammatory drugs and anakinra. Eight studies reported improved outcomes associated with non-pharmacological interventions: inpatient rheumatology consultation and a hospital gout management protocol. No studies to date have prospectively evaluated strategies designed to prevent re-admissions in patients hospitalised for gout flares.
CONCLUSION: There is an urgent need for high quality, prospective studies of strategies to improve uptake of urate-lowering therapies in hospitalised patients, incorporating prophylaxis against flares and treat-to-target optimisation of serum urate levels. Such studies are essential if the epidemic of hospital admissions from this treatable condition is to be countered.
Citation
Roddy. (2021). Improving outcomes for patients hospitalised with gout: a systematic review. Rheumatology, 90-102. https://doi.org/10.1093/rheumatology/keab539
Acceptance Date | Jul 10, 2021 |
---|---|
Publication Date | Jul 10, 2021 |
Journal | Rheumatology (Oxford) |
Print ISSN | 1462-0324 |
Publisher | Oxford University Press |
Pages | 90-102 |
DOI | https://doi.org/10.1093/rheumatology/keab539 |
Keywords | gout, hospital, admission, emergency, inpatient, prevention, urate-lowering therapy, allopurinol, febuxostat |
Publisher URL | https://doi.org/10.1093/rheumatology/keab539 |
Files
keab539.pdf
(270 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
A Genome-Wide Association Analysis of 2,622,830 Individuals Reveals New Pathogenic Pathways in Gout
(2022)
Presentation / Conference
Gout: diagnosis and management-summary of NICE guidance.
(2022)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search